M0075 HCPCS Level II code: Cellular therapy
M0075 is the HCPCS code for “Cellular therapy” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
M0075Cellular therapy
HCPCS · United States
Medicare details
The indicators CMS publishes with M0075 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Non-covered by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Other - Non-Medicare fee schedule
- Added
- Jan 1, 1986
Where M0075 sits
- 1M codesMedical services and quality measures
- 2Active code M0075Cellular therapy
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code M0075 mean?
M0075 is the HCPCS code for “Cellular therapy” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover M0075?
CMS lists M0075’s Medicare coverage as “Non-covered by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside M0075
All M codesM0002Optimal care for kidney health mips value pathwaysM0003Optimal care for patients with episodic neurological conditions mips value pathwaysM0004Quality care for patients with neurological conditions mips value pathwayM0005Value in primary care mips value pathwayM0010Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced servicesM0064Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disordersM0076ProlotherapyM0100Intragastric hypothermia using gastric freezingM0201Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such…M0220Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with…M0221Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with…M0222Intravenous injection, bebtelovimab, includes injection and post administration monitoring